Metallothionein-vasopressin fusion gene expression in transgenic mice. Nephrogenic diabetes insipidus and brain transcripts localized to magnocellular neurons

J. F. Habener, B. J. Cwikel, H. Hermann, Robert E Hammer, R. D. Oalmiter, R. L. Brinster

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Arginine vasopressin (AVP) is a potent neuroactive and vasoactive nonapeptide encoded in and processed from a precursor, preproarganine vasopressin-neurophysin II (preproAVP-NPII). To study the physiologic consequences of a genetic model of chronic hypervasopressinemia transgenic mice were produced by introduction of a mouse metallothionein-rat-ppAVP-NPII fusion gene into the germ line of mice. Three stable transgenic pedigrees were analyzed through several generations. Levels of immunoreactive AVP and neurophysin (NP) in sera, livers, kidneys, intestines, pancreas, and brains were markedly elevated. Chromatographic analyses showed sera levels of approximately 400 pg/ml (normal 0-20 pg/ml) of authentic AVP nonapeptide and serum osmolalities were elevated, 315.4 ± 1.4 mosm/liter (control, 307.3 ± 1.1), consistent with a state of mild nephrogenic diabetes insipidus. Brain levels of immunoreactive AVP in transgenic mice were 3-4-fold elevated 145 ± 15 ng/g versus 31 ± 7 (controls). Although immunoreactive AVP in livers and intestines, and to some extent kidneys, consisted predominantly of unprocessed precursors, in brain and pancreas >90% of AVP consisted of processed bioactive nonapeptide, as determined by chromatography and measurements of cAMP-generation in LLC-PK1 cells. Immunocytochemistry localized immunoreactive AVP to the exocrine pancreas and to the magnacellular neurons (SON and PVN) of the hypothalamus. Expression of the fusion gene in the hypothalamus was further demonstrated by Northern analyses of fusion gene specific transcripts and in situ histohybridization. Although the fusion gene contained only 35 base pais of 5'-flanking DNA and the ppAVP-NPII gene, a tentative neuronal cell-specific expression element, -17GCCCAGCC-10 resides in the sequence and may confer neuron-specific expression to the fusion gene.

Original languageEnglish (US)
Pages (from-to)18844-18852
Number of pages9
JournalJournal of Biological Chemistry
Volume264
Issue number31
StatePublished - 1989

Fingerprint

Nephrogenic Diabetes Insipidus
Arginine Vasopressin
Metallothionein
Medical problems
Vasopressins
Gene expression
Transgenic Mice
Neurons
Brain
Gene Fusion
Fusion reactions
Genes
Gene Expression
Neurophysins
Liver
Hypothalamus
Intestines
Chromatography
Pancreas
Serum

ASJC Scopus subject areas

  • Biochemistry

Cite this

Metallothionein-vasopressin fusion gene expression in transgenic mice. Nephrogenic diabetes insipidus and brain transcripts localized to magnocellular neurons. / Habener, J. F.; Cwikel, B. J.; Hermann, H.; Hammer, Robert E; Oalmiter, R. D.; Brinster, R. L.

In: Journal of Biological Chemistry, Vol. 264, No. 31, 1989, p. 18844-18852.

Research output: Contribution to journalArticle

@article{3d1cb473968b4f02a6f1571c8230912d,
title = "Metallothionein-vasopressin fusion gene expression in transgenic mice. Nephrogenic diabetes insipidus and brain transcripts localized to magnocellular neurons",
abstract = "Arginine vasopressin (AVP) is a potent neuroactive and vasoactive nonapeptide encoded in and processed from a precursor, preproarganine vasopressin-neurophysin II (preproAVP-NPII). To study the physiologic consequences of a genetic model of chronic hypervasopressinemia transgenic mice were produced by introduction of a mouse metallothionein-rat-ppAVP-NPII fusion gene into the germ line of mice. Three stable transgenic pedigrees were analyzed through several generations. Levels of immunoreactive AVP and neurophysin (NP) in sera, livers, kidneys, intestines, pancreas, and brains were markedly elevated. Chromatographic analyses showed sera levels of approximately 400 pg/ml (normal 0-20 pg/ml) of authentic AVP nonapeptide and serum osmolalities were elevated, 315.4 ± 1.4 mosm/liter (control, 307.3 ± 1.1), consistent with a state of mild nephrogenic diabetes insipidus. Brain levels of immunoreactive AVP in transgenic mice were 3-4-fold elevated 145 ± 15 ng/g versus 31 ± 7 (controls). Although immunoreactive AVP in livers and intestines, and to some extent kidneys, consisted predominantly of unprocessed precursors, in brain and pancreas >90{\%} of AVP consisted of processed bioactive nonapeptide, as determined by chromatography and measurements of cAMP-generation in LLC-PK1 cells. Immunocytochemistry localized immunoreactive AVP to the exocrine pancreas and to the magnacellular neurons (SON and PVN) of the hypothalamus. Expression of the fusion gene in the hypothalamus was further demonstrated by Northern analyses of fusion gene specific transcripts and in situ histohybridization. Although the fusion gene contained only 35 base pais of 5'-flanking DNA and the ppAVP-NPII gene, a tentative neuronal cell-specific expression element, -17GCCCAGCC-10 resides in the sequence and may confer neuron-specific expression to the fusion gene.",
author = "Habener, {J. F.} and Cwikel, {B. J.} and H. Hermann and Hammer, {Robert E} and Oalmiter, {R. D.} and Brinster, {R. L.}",
year = "1989",
language = "English (US)",
volume = "264",
pages = "18844--18852",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "31",

}

TY - JOUR

T1 - Metallothionein-vasopressin fusion gene expression in transgenic mice. Nephrogenic diabetes insipidus and brain transcripts localized to magnocellular neurons

AU - Habener, J. F.

AU - Cwikel, B. J.

AU - Hermann, H.

AU - Hammer, Robert E

AU - Oalmiter, R. D.

AU - Brinster, R. L.

PY - 1989

Y1 - 1989

N2 - Arginine vasopressin (AVP) is a potent neuroactive and vasoactive nonapeptide encoded in and processed from a precursor, preproarganine vasopressin-neurophysin II (preproAVP-NPII). To study the physiologic consequences of a genetic model of chronic hypervasopressinemia transgenic mice were produced by introduction of a mouse metallothionein-rat-ppAVP-NPII fusion gene into the germ line of mice. Three stable transgenic pedigrees were analyzed through several generations. Levels of immunoreactive AVP and neurophysin (NP) in sera, livers, kidneys, intestines, pancreas, and brains were markedly elevated. Chromatographic analyses showed sera levels of approximately 400 pg/ml (normal 0-20 pg/ml) of authentic AVP nonapeptide and serum osmolalities were elevated, 315.4 ± 1.4 mosm/liter (control, 307.3 ± 1.1), consistent with a state of mild nephrogenic diabetes insipidus. Brain levels of immunoreactive AVP in transgenic mice were 3-4-fold elevated 145 ± 15 ng/g versus 31 ± 7 (controls). Although immunoreactive AVP in livers and intestines, and to some extent kidneys, consisted predominantly of unprocessed precursors, in brain and pancreas >90% of AVP consisted of processed bioactive nonapeptide, as determined by chromatography and measurements of cAMP-generation in LLC-PK1 cells. Immunocytochemistry localized immunoreactive AVP to the exocrine pancreas and to the magnacellular neurons (SON and PVN) of the hypothalamus. Expression of the fusion gene in the hypothalamus was further demonstrated by Northern analyses of fusion gene specific transcripts and in situ histohybridization. Although the fusion gene contained only 35 base pais of 5'-flanking DNA and the ppAVP-NPII gene, a tentative neuronal cell-specific expression element, -17GCCCAGCC-10 resides in the sequence and may confer neuron-specific expression to the fusion gene.

AB - Arginine vasopressin (AVP) is a potent neuroactive and vasoactive nonapeptide encoded in and processed from a precursor, preproarganine vasopressin-neurophysin II (preproAVP-NPII). To study the physiologic consequences of a genetic model of chronic hypervasopressinemia transgenic mice were produced by introduction of a mouse metallothionein-rat-ppAVP-NPII fusion gene into the germ line of mice. Three stable transgenic pedigrees were analyzed through several generations. Levels of immunoreactive AVP and neurophysin (NP) in sera, livers, kidneys, intestines, pancreas, and brains were markedly elevated. Chromatographic analyses showed sera levels of approximately 400 pg/ml (normal 0-20 pg/ml) of authentic AVP nonapeptide and serum osmolalities were elevated, 315.4 ± 1.4 mosm/liter (control, 307.3 ± 1.1), consistent with a state of mild nephrogenic diabetes insipidus. Brain levels of immunoreactive AVP in transgenic mice were 3-4-fold elevated 145 ± 15 ng/g versus 31 ± 7 (controls). Although immunoreactive AVP in livers and intestines, and to some extent kidneys, consisted predominantly of unprocessed precursors, in brain and pancreas >90% of AVP consisted of processed bioactive nonapeptide, as determined by chromatography and measurements of cAMP-generation in LLC-PK1 cells. Immunocytochemistry localized immunoreactive AVP to the exocrine pancreas and to the magnacellular neurons (SON and PVN) of the hypothalamus. Expression of the fusion gene in the hypothalamus was further demonstrated by Northern analyses of fusion gene specific transcripts and in situ histohybridization. Although the fusion gene contained only 35 base pais of 5'-flanking DNA and the ppAVP-NPII gene, a tentative neuronal cell-specific expression element, -17GCCCAGCC-10 resides in the sequence and may confer neuron-specific expression to the fusion gene.

UR - http://www.scopus.com/inward/record.url?scp=0024435793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024435793&partnerID=8YFLogxK

M3 - Article

C2 - 2808395

AN - SCOPUS:0024435793

VL - 264

SP - 18844

EP - 18852

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 31

ER -